title: Imiquimod 5% cream for keloid management.
abstract: BACKGROUND
  Keloid treatment represents a therapeutic challenge. New adjuvant therapy is needed to reduce the high recurrence rate (50%) of excised keloids.
  
  
  OBJECTIVE
  To describe the method for using imiquimod 5% cream in the prevention of keloid recurrence after surgery.
  
  
  METHODS
  This is a review of the scientific rationale and clinical experience of using imiquimod 5% cream for keloid management.
  
  
  CONCLUSIONS
  Topical application of imiquimod 5% cream after surgery reduces keloid recurrences.
authors.affiliation: Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, FL 33136, USA. bberman@med.miami.edu
authors.forename: Brian
authors.initials: B
authors.lastname: Berman
authors.forename: Adriana
authors.initials: A
authors.lastname: Villa
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000287:Administration, Topical; D000634:Aminoquinolines / Q000008:administration & dosage*; D017024:Chemotherapy, Adjuvant / Q000379:methods; D006801:Humans; D000077271:Imiquimod; D007627:Keloid / Q000188:drug therapy* / Q000517:prevention & control* / Q000601:surgery; D055502:Secondary Prevention; D013514:Surgical Procedures, Operative
chemical_list: D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D000077271:Imiquimod